Form Type: 4

SEC EDGAR Link
Accession Number:0000950103-20-002994
Date:2020-02-18
Issuer: SHOCKWAVE MEDICAL, INC. (SWAV)
Original Submission Date:

Reporting Person:

GODSHALL DOUGLAS EVAN
C/O SHOCKWAVE MEDICAL, INC.
5403 BETSY ROSS DRIVE SANTA CLARA, CA 95054

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-18 M 30,000 a $3.42 46,000 direct
COMMON STOCK 2020-02-18 S 16,817 d $42.82 29,183 direct
COMMON STOCK 2020-02-18 S 13,183 d $43.75 16,000 direct
COMMON STOCK 2020-02-18 A 84,200 a $0.00 100,200 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 3.416 2020-02-18 deemed execution date M 30,000 (d) 2027-05-09 common stock 30,000 $3.42 1,124,799 direct
Footnotes
IDfootnote
f1 this exercise and all sale transactions reported here were effected pursuant to a rule 10b5-1 plan adopted by the reporting person on 9/6/2019.
f2 the price reported in column 4 is a weighted average price. the reported securities were sold in multiple transactions at prices ranging from $42.39 to $43.36. the reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within such range.
f3 the price reported in column 4 is a weighted average price. the reported securities were sold in multiple transactions at prices ranging from $43.45 to $44.04. the reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within such range.
f4 twenty-five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.
WhaleWisdom Logo

Elevate your investments